Real-world quality of life (QoL) in patients with HR+/HER2− advanced breast cancer (ABC) treated with palbociclib: Final clinical outcome assessment (COA) analysis from POLARIS - Rocque, G; Blum, JL; Ji, Y (Ann Oncol, 2022)